Journal article icon

Journal article

Assessing the impact of MRI based diagnostics on pre-treatment disease classification and prognostic model performance in men diagnosed with new prostate cancer from an unscreened population

Abstract:
Purpose of review: To review the current risk and prognostic stratification systems in localised prostate cancer. To explore some of the most promising adjuncts to clinical models and what the evidence has shown regarding their value. Recent findings: There are many new biomarker-based models seeking to improve, optimise or replace clinical models. There is promising data on the value of MRI, radiomics, genomic classifiers and most recently artificial intelligence tools in refining stratification. Despite the extensive literature however, there remains uncertainty on where in pathways they can provide the most benefit and whether a biomarker is most useful for prognosis or predictive use. Comparisons studies have also often overlooked the fact that clinical models have themselves evolved and the context of the baseline used in studies that have shown superiority have to be considered. Summary: For new biomarkers to be included in stratification models, well designed prospective clinical trials are needed. Until then, there needs to be caution in interpretation of their use for day to day decision making. It is critical that users balance any purported incremental value against the performance of the latest clinical classification and multivariate models especially as the latter are cost free and widely available
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Files:
Publisher copy:
10.1186/s12885-022-09955-w

Authors

More by this author
Role:
Author
ORCID:
0000-0003-0550-4657
More by this author
Institution:
University of Oxford
Role:
Author
ORCID:
0000-0002-2414-352X
More by this author
Role:
Author
ORCID:
0000-0002-1180-1474
More by this author
Role:
Author
ORCID:
0000-0002-1170-7867
More by this author
Role:
Author
ORCID:
0000-0001-6429-988X


Publisher:
BioMed Central
Journal:
BMC Cancer More from this journal
Volume:
22
Issue:
1
Pages:
878-878
Article number:
878
Publication date:
2022-08-11
DOI:
EISSN:
1471-2407
ISSN:
1471-2407


Language:
English
Keywords:
Pubs id:
1494773
Local pid:
pubs:1494773
Source identifiers:
W4291016750
Deposit date:
2026-05-11
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP